# BENDAMUSTINE HYDROCHLORIDE
> **ANDA205574** · Abbreviated New Drug Application (Generic) · Sponsor: ACCORD HLTHCARE · Approved 2022-12-07
## Drug
- **FDA Application Number:** ANDA205574
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BENDAMUSTINE HYDROCHLORIDE
- **Generic name:** BENDAMUSTINE HYDROCHLORIDE
- **Active ingredients:** BENDAMUSTINE HYDROCHLORIDE
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** ACCORD HLTHCARE
- **Manufacturer:** Accord Healthcare, Inc.
- **First approval:** 2022-12-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205574)
---
*MORVS · CC0 1.0*